Cannabis Commercialization in California: What It Means
TL;DR
Since California legalized cannabis in 2016, the cannabis industry has commercialized rapidly — growing stronger, more potent products, aggressive marketing, and wider accessibility. Modern cannabis is far more potent than cannabis from 20 years ago (average THC has risen from 4% to 15%+). Commercialization has benefits (regulated products, tax revenue, reduced incarceration) and risks (higher potency, youth marketing, normalization that may increase use in vulnerable populations). The evidence suggests commercialization increases cannabis-related mental health issues, particularly in young people and those with a family history of psychosis.
Anchored Tides Clinical TeamReviewed by Zoe Tambling, LMFT
Published January 30, 2025Last updated: January 2026
“ATR has been a wonderful organization to work with. I've partnered with them on many occasions on behalf of my own clients. They're trustworthy, ethical and provide excellent clinical care to the women they serve.”
Since California legalized recreational cannabis in 2016, the cannabis industry has exploded. Dispensaries, edibles, concentrates, and cannabis brands are now ubiquitous. But what does this commercialization mean for public health, potency, and who's using cannabis? Here's what the evidence shows.
The Growth of California's Cannabis Market
Legal sales have skyrocketed:
2017: ~$2.5 billion in legal sales
2023: ~$6+ billion (and growing)
Dispensaries: 1,000+ legal retailers across California
Higher potency = greater risk of cannabis use disorder
Higher potency associated with more psychosis risk, especially in vulnerable people
Edibles are particularly risky because people underestimate potency and dosing
Benefits of Commercialization
Legalization and commercialization have had real benefits:
Reduced incarceration. Cannabis arrests have dropped dramatically, reducing criminal records for low-level possession.
Regulated products. Legal products are tested for contaminants, pesticides, and potency. Black market products have no oversight.
Tax revenue. California's cannabis taxes have generated billions for education, drug treatment, and public health.
Medical access. People can legally access cannabis for legitimate medical purposes without fear of arrest.
Reduced black market. Legal sales have undercut illegal producers (though black market still exists due to high taxes and licensing barriers).
Risks of Commercialization
But commercialization comes with serious public health concerns:
Increased potency = increased risk. Higher-potency products increase risk of dependence, psychosis, and other adverse effects — especially in adolescents and people with genetic vulnerability to psychosis.
Youth access and normalization. Legalization and normalization may increase youth use. Some studies show cannabis use has increased in teens since legalization, though the evidence is mixed.
Marketing to vulnerable populations. Cannabis brands use imagery and messaging that appeals to young people, people of color, and other vulnerable groups.
Mental health impacts. Increasing evidence suggests commercialization and higher potency are linked to rising cannabis-related psychosis and mental health issues.
Driving risk. More accessible cannabis may increase driving under the influence (though the evidence is still developing).
Who Uses Cannabis Now?
Legalization has changed cannabis users:
More adults. Adult use has increased, particularly middle-aged and older adults
More women. Women's cannabis use has increased
Wider demographic range. Cannabis use is less concentrated in specific subgroups
Youth. Teen use has plateaued or slightly increased (evidence is mixed), despite legalization not changing youth access laws
Mental health vulnerability: People with a family history of psychosis, schizophrenia, or bipolar disorder are at higher risk for adverse mental health effects from cannabis — especially high-potency products.
The Broader Picture
Cannabis commercialization reflects a tension: legalization can reduce harm (incarceration, unregulated products) while simultaneously creating new harms (higher potency, wider access, normalization for vulnerable groups).
The evidence suggests:
Legalization has reduced some harms (criminal justice system)
Commercialization has created new harms (potency, youth access, mental health impacts)
Currently, California's regulations are somewhat lax compared to other jurisdictions
Frequently asked questions
Is legal cannabis safer than black market cannabis?
Safer, yes — legal cannabis is tested and regulated. But "safe" is relative. High-potency legal products still carry risks, especially for vulnerable people.
Has cannabis legalization reduced youth use?
The evidence is mixed. Some states show slight increases in youth use; others show no change. The relationship between legalization and youth use is complex and not fully understood.
Can commercialization be regulated better?
Yes. Potency caps, marketing restrictions (similar to alcohol and tobacco), and stricter youth access controls are policy options some jurisdictions are considering.
Is cannabis addictive?
Yes. Cannabis use disorder (addiction) affects about 9% of users (higher in people who start young or use daily). High-potency products increase this risk.
What are the mental health risks?
Cannabis can trigger or worsen psychosis, especially in people with vulnerability. It can increase anxiety and depression in some users. High-potency products carry higher risk.
Evidence & accountability
Sources and clinical review
This page was reviewed by Zoe Tambling, LMFT on . The references below informed the specific topics noted with each citation.
California Cannabis LawsCalifornia Department of Cannabis ControlSupports: California’s legal cannabis framework and regulatory requirements
Cannabis and Public HealthCenters for Disease Control and PreventionSupports: Public-health effects and risks associated with cannabis use
Ready to take the next step?
Call (866) 329-6639 or verify your insurance — confidential, no obligation. Women-only environment, Joint Commission accredited.
